US FDA approves Pfizer's drug for growth hormone deficiency

In this article:

June 28 (Reuters) - The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)

Advertisement